Loading clinical trials...
Loading clinical trials...
This is a Phase II, Randomized, Blinded, Sham Procedure-Controlled, Parallel-Group Trial to Evaluate the Efficacy, Safety and Tolerability of LYR-210 in Adult Subjects with Chronic Sinusitis.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Lyra Therapeutics
NCT04469439 · Chronic Rhinosinusitis (Diagnosis), Cystic Fibrosis
NCT05427695 · Chronic Rhinosinusitis (Diagnosis)
NCT06822725 · Sinonasal Disorder, Chronic Rhinosinusitis (Diagnosis)
NCT03970655 · Chronic Rhinosinusitis (Diagnosis)
NCT07528820 · CRSwNP, Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis
Royal Brisbane and Woman's Hospital
Brisbane
Monash Health
Clayton
The ENT Centre
Hornsby
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions